Advanced Ocular Systems Ltd. Featured In The Global Learning Series Television Production Of 'Understanding The Human Eye'

Published: Apr 21, 2006

MARBLEHEAD, Mass., April 21 /PRNewswire-FirstCall/ -- Advanced Ocular Systems Ltd. , a global ophthalmic company, will soon be featured internationally on broadcast television. The Global Learning Series, a sponsor of educational programming, has invited AOS to participate in a feature segment entitled "Understanding The Human Eye," which will air on public television stations throughout the United States this summer. The 2-5 minute segment may be seen on networks in the top 30 markets including CNN, Fox News, MSNBC, Lou Dobbs Tonight, Larry King Live, Day Break, Newsnight, On the Record with Greta Van Susteren, and other prime and peak time programs. The presentation, which highlights AOS' innovative technologies in the treatment of refractive diseases, will also air on CNN's airport network in 39 major airports and on Voice of America programming internationally.

"We are honored to take part in The Global Learning Series to offer some insight into the evolving field of ophthalmology" said Dr. Ken Taylor, O.D., President and CEO of AOS. "At AOS, we are striving to bring novel therapies and products to the market to better serve an increasing population of mature adults with common age-related vision disorders, as well as improved treatments for serious, often blinding, eye diseases."

John McGuire, Senior Producer for The Global Learning Series added "We are proud to partner with Advanced Ocular Systems Ltd. to educate the public and the medical community about vision correction issues that are of utmost importance to an aging population."

The Global Learning Series features non-commercial, educational breakthroughs and is independently produced and distributed by Global Television Studios directly to public television stations around the United States. The Global Learning Series strictly follows the standards and practices of public television, and is distributed freely to public television stations in all 50 states. Global Television Studios and its programming are not affiliated with PBS.

For program information visit

About Advanced Ocular Systems :

Advanced Ocular Systems Ltd. (previously Regenera Ltd.) focuses on the development and commercialization of innovative ocular pharmaceuticals and refractive surgical devices. AOS has a substantial technology portfolio spanning pharmaceuticals and refractive surgical devices that treat a range of ocular diseases and visual disorders. The pharmaceutical portfolio includes retinal drugs and devices for precisely delivering these drugs for the treatment of age related macular degeneration, diabetic macular edema, and diseases of the vitreous.

In 2005, the company licensed an ocular use of the steroid, triamcinolone acetonide, to the leading international ophthalmology company, Alcon. The company's refractive surgical devices minimize the need for wearing eyeglasses or contact lenses, improving distance vision as well as near vision for patients with presbyopia.

AOS listed on the ASX on June 16, 2004. On December 30, 2005, the company merged with the US-based refractive devices company Advanced Ocular Systems, Inc., and now has its corporate headquarters and management of refractive technology in Massachusetts, USA and registered office and drug development management in Perth, Western Australia.

Advanced Ocular Systems Ltd.

CONTACT: Seth Lewis, Associate, The Trout Group, LLC, +1-617-583-1308,

Back to news